Acupuncture Shown to Relieve Tension Headaches
Posted on: Friday, 29 July 2005, 06:30 CDT
LONDON -- Acupuncture is an effective treatment for patients suffering from tension headaches, German researchers said on Friday.
The ancient Chinese therapy that involves inserting very fine needles into the skin at specific sites on the body cut the rates of headaches by nearly half in a study of 270 people.
"A significant proportion of patients with tension-type headaches benefited from acupuncture," said Dr Wolfgang Weidenhammer, of the Center for Complementary Medicine Research at Technische Universitat in Munich.
"Acupuncture was well tolerated and improvements lasted several months after completion of treatment," he added.
Weidenhammer and his team compared traditional Chinese acupuncture, minimal acupuncture in which the needles are inserted superficially in the skin, and no treatment.
The headaches rate in patients given the traditional treatment over eight weeks dropped by almost half. They experience 7 fewer days of headaches in the four weeks following treatment.
Patients who had minimal acupuncture had a similar result, or 6.6 fewer headache days, while the control group which received no treatment had 1.5 fewer headache days.
"The lack of significant differences between acupuncture and minimal acupuncture in our study indicates that point location and other aspects considered relevant for traditional Chinese acupuncture did not make a major difference," Weidenhammer said in a report in the British Medical Journal.
Some patients in the acupuncture group reported side effects which included dizziness and bruising.
Acupuncture, which is one of the most popular complementary treatments, has also been shown to relieve nausea, stress, arthritis pain in the knee and pelvic pain during pregnancy.
Source: REUTERS
Related Articles
- MDCT Angiography Helps Lead to Successful Treatment of Patients
- Nursing Research Grants Available to Improve Treatment of Patients With Auto-Immune Diseases and Cancer
- CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
- Data Presented at This Year's ASCO Meeting Provide New Insights into the Treatment of Patients With Myelodysplastic Syndromes
- Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
- Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
- New Data From Largest U.S. Hepatitis C Trial Provide Insights Into Optimizing Treatment for Patient Populations Traditionally Considered Difficult to Treat
- New Treatment Guidelines Support Use of FUZEON(R) to Achieve Undetectable HIV in Treatment-Experienced Patients
- Going Under the Needle Acupuncture Treatments Turn Some Skeptics into Believers
- Results of Phase IIa Study Show That Reverset Has Potential to Reduce HIV Viral Load in Treatment-Experienced Patients
 |
 |
User Comments (0)
RSS Feeds